#JustPublished!
A joint #ECDC - @EMA_News statement on updating #COVID19 vaccines composition for new #SARSCoV2 virus variants.
Read full here:
bit.ly/42wARAa
Currently authorised vaccines continue to be effective at preventing hospitalisation, severe disease and death due to #COVID19.
However, protection against the virus declines over time as new #SARSCoV2 variants emerge.
In line with the outcome of recent meetings of international regulators and the @WHO, @EMA_News Emergency Task Force recommends updating vaccines to target #XBB strains (a subgroup of #Omicron), which have become dominant in Europe and other parts of the world.
Both agencies (@ECDC_EU & @EMA_News) note that monovalent vaccines (vaccines targeting only one strain such as XBB.1.5) are a reasonable choice to provide protection against current dominant and emerging strains.
#COVID19
Timely vaccination ahead of a potential autumn and winter 2023 surge of #COVID19 cases is essential for protecting people from severe COVID-19 and health systems from being overwhelmed.
Share this Scrolly Tale with your friends.
A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.